Dear Editor,
It is well known that caspase-8 is an ‘initiator’ caspase acting at the top of the apoptotic cascade.1,2,3 Specific ligand engagement by death receptors of the TNF-R superfamily or CD95/FAS induces receptor aggregation and recruitment of the Fas-associated death domain and caspase-8 molecules.4,5 Thus, caspase-8 becomes activated and further activates, by enzymatic cleavage, the downstream ‘effector’ caspases.6,7 The silencing of caspase-8 gene was observed in several tumors, where it was related to resistance to death-inducing ligands, such as TNFα, TRAIL or CD95/FAS.8,9 It has been proposed that in aggressive human neuroblastomas (NB), silencing of caspase-8 depends on methylation of a regulatory region at the boundary between caspase-8 exon-3 and intron-3.10
Interferon (IFN)-γ has been shown to sensitize several malignant cells to apoptosis11,12,13 through upregulation of caspase-8 expression.12,13 Intriguingly, IFN-γ also induced caspase-8 expression in tumor cells having a hypermethylated caspase-8 gene, without affecting DNA methylation.12 In addition, we recently showed that the transcriptional inactivation of caspase-8 gene is independent of CpG methylation of this gene in a fraction of primary NB.14 These observations led us to the first identification of a 1.2 kb DNA element, located 5′ to the first exon of caspase-8 gene, which acts as a promoter in NB cell lines that express caspase-8, but not in NB cells that lack constitutive expression of this gene.14
Here, we studied the mechanisms of caspase-8 gene regulation by IFN-γ in the SH-SY-5Y NB cells, which showed virtually no constitutive expression of caspase-8. The treatment of SH-SY-5Y cells with IFN-γ for 48 h induced a strong caspase-8 expression (Figure 1a). Since several IFN-γ-sensitive genes are regulated through the STAT-1/IRF-1 pathway,15,16,17,18,19 we studied the activation of this signal transduction pathway in these cells. IFN-γ signaling first induces phosphorylation of JAK-1 and -2, which in turn activate STAT-1 by phosphorylation. pSTAT-1α homodimers directly induce the transcription of specific genes, including the transcription factor IRF-1,17 which further activates other IFN-γ-sensitive genes.18,19 Induction of the phosphorylated form of STAT-1 was detected in SH-SY-5Y cells by a specific antiserum to p-tyr 701 of STAT-1, 20 min after IFN-γ stimulation (Figure 1a). Moreover, the transcription factor IRF-1 was strongly upregulated 24 h after stimulus, indicating that the STAT-1/IRF-1 pathway is active in these NB cells, and could be involved in caspase-8 gene transcriptional control. IRF-2, an IFN-γ-related factor regulating IRF-1 binding to the ISRE and/or its activity, was constitutively expressed in SH-SY-5Y NB cells and also appeared to be upregulated by IFN-γ. Finally, the upstream factor USF-1, involved in the transcriptional coactivation of several IFN-γ-dependent genes, was also constitutively expressed.
Prior to promoter regulation studies, we investigated the caspase-8 transcription initiation site(s) by RACE analysis, using exon-5-specific primers (data not shown). Sequencing of RACE products indicated that caspase-8 transcripts mostly originated at the position −20 of the caspase-8 cDNA reference sequence (NM_001228), although the finding of fragments of different length suggested the possible existence of other transcription initiation sites. Indeed, a different caspase-8 transcription initiation start site was recently reported by primer extension studies in human hepatoma cell lines.20 We then tested the possible regulation of the promoter P-1161/+16 (Figure 1b) by IFN-γ. Treatment with IFN-γ induced CAT expression in P-1161/+16/CAT-transfected SH-SY-5Y cells (Figure 1c), indicating that the P-1161/+16 fragment contains IFN-γ-inducible regulatory elements. Two GAS elements (at positions −787 and −188) potentially capable of binding pSTAT-1 and two ISRE (at −567 and −32) were found in this region (Figure 1b). An additional ISRE at −38 was partially overlapped with the ISRE-32. In addition, two E-boxes, potentially capable of binding the USF-1 transcription factor, were also present at positions −95 and −54.
To better characterize the elements required for promoter activity, we further performed deletion studies. Fragments of 167, 368, 600 and 843 bp, respectively, named P-151/+16, -352/+16, -584/+16 and -827+16, having the same 3′ end were generated by PCR amplification, sequenced and cloned into the CAT reporter plasmid (Figure 1b). When transfected into SH-SY-5Y cells, all these DNA fragments showed no promoter activity, although CAT expression was upregulated after IFN-γ treatment (Figure 1d). Interestingly, the promoter activity of P-151/+16 was strongly upregulated, indicating that P-151/+16 represents a ‘minimal’ IFN-γ-sensitive promoter. Moreover, the ISRE at position −38 and/or −32 should play a pivotal role in IFN-γ-induced transcriptional regulation, since no other potential IRF-1 or STAT-1-binding sites were present in P-151/+16.
On the basis of computer analysis, ISRE-32 is more similar to the canonical IRF-1-binding site than ISRE-38. To study the functional role of the ISRE at position −32 in the promoter context, we generated P-1161/+16 and P-584/+16/CAT constructs, where only the ISRE-32 site was disrupted by a point mutation (Figure 1e). Both these mutated constructs were inactive as promoters in IFN-γ-treated SH-SY-5Y, confirming the critical role of this site in the transcriptional regulation of caspase-8 by IFN-γ (Figure 1e).
To prove that the minimal promoter fragment is actually capable of binding IRF-1, IRF-2 and USF-1 transcription factors, we used a 5′ biotin-labeled P-151/+16 DNA fragment immobilized to streptavidin-magnetic beads. Nuclear extracts from IFN-γ-treated or -untreated SH-SY-5Y cells were allowed to react with immobilized promoter P-151/+16, and bound proteins were analyzed by Western blotting using IRF-1-, IRF-2- or USF-1-specific antibodies. As shown in Figure 1f, a specific 48 kDa band corresponding to IRF-1 was clearly present in the eluted fraction from IFN-γ-treated SH-SY-5Y cells extracts. IRF-1 binding was specifically competed by the addition of an excess of free P-151/+16 DNA. IRF-2 and USF-1 were also capable of binding to the minimal promoter sequence, using nuclear extracts from both untreated or IFN-γ-treated SH-SY-5Y cell lines. The use of an immobilized DNA deleted of the ISRE (P-151/−40) showed no IRF-1 or IRF-2 in the eluted fraction from the same nuclear extracts (not shown).
Our data indicate that IFN-γ is capable of upregulating the transcriptional activity of a caspase-8 promoter, which we have identified in the genomic region 5′ flanking caspase-8 and exon-1. Although this region contains two STAT-1 and three IRF-1 potential binding sites, which may play a role in caspase-8 regulation in vivo, both promoter deletion analysis and site-specific mutagenesis showed that the ISRE-32, proximal to exon-1, is essential for the IFN-γ-mediated promoter activation. However, this finding does not deny the possibility that the other IRF-1- and STAT-1-binding sites may play a role in vivo in a more complex nuclear environment. Previous reports pointed out the importance of STAT-1 in the regulation of caspase-8 gene by IFN-γ, since STAT-1-deficient T cells21 or U3A cells12 are resistant to apoptosis due to their lack of caspase-8 expression, and could not be induced to express caspase-8 by IFN-γ. A recent report indicated that a GAS site within a caspase-8 promoter, similar to that identified by us,14 plays an important role in caspase-8 gene regulation.13 In view of the complexity of the caspase-8 genomic region, and the existence of several caspase-8 isoforms,4,5,22,23 the presence of other caspase-8 promoter(s), possibly regulating inducible and/or constitutive expression cannot be definitively ruled out.10
Multiple promoters have been reported for other genes, such as the MHC-class II-transcriptional transactivator CIITA.16 In the IFN-γ-sensitive CIITA P-IV promoter, pSTAT-1 homodimers play a direct role in transcriptional regulation by binding to GAS sequence(s) in concert with IRF-1, IRF-2 and USF-1.24 Our findings that the activity of the caspase-8 minimal promoter (P-151/+16), lacking a GAS sequence, is upregulated by IFN-γ suggest that STAT-1 plays an important indirect role in the regulation of caspase-8, through the induction of IRF-1. DNA–protein interaction studies indeed showed that IRF-1 is capable of binding to the minimal promoter P-151/+16. Similarly, in other IFN-γ-sensitive genes, such as the catepsin-S,17 a single IRF-1-binding site located upstream the transcription start site was found to be critical for transcriptional activation. The important role of IRF-1 in caspase-8 regulation was also evidenced by a previous study showing that the gene transfer of IRF-1 is sufficient to restore the expression of caspase-8 and sensitivity to apoptosis in NB cells lacking constitutive caspase-8 expression.17
The finding that not only IRF-1 but also IRF-2 binds to the minimal promoter sequence, points to a role of IRF-2 in the regulation of caspase-8 gene expression. However, the constitutive expression of IRF-2 in cells lacking the expression of caspase-8 indicates that IRF-2 alone is unable to activate caspase-8 promoter. In other promoters, it has been proposed that IRF-2 may act either as a negative regulator of the IRF-1-mediated promoter activation,25 or, on in contrast, as a cooperative factor acting in concert with IRF-1.24
The finding that a point mutation in the ISRE-32 completely abrogates IFN-γ-inducible promoter activity is not a unique feature of this promoter, since other studies reported similar findings on different promoters. It has been proposed that mutations in these regulatory regions may alter the conformation of the transcription factor/chromatin complex, thus preventing the coordinate interaction with other factors required for the formation of a functional enhanceosome or transcriptosome.26,27
The ubiquitous transcriptional activator USF-1 is known to bind upstream E-boxes in other IFN-γ-sensitive promoters, and to play a relevant role in transcriptional activation through pSTAT-1 or IRF-128,29 interaction with their specific binding sites. Thus, the detection of two E-boxes at positions −95 and −54, upstream the critical ISRE-32, and the detection of USF-1 binding to this caspase-8 promoter region, strongly support a role of USF-1 in the transcriptional regulation of caspase-8.
These data may provide a better understanding of the molecular mechanisms involved in caspase-8 gene transcriptional regulation and in the related cellular sensitivity to apoptotic stimuli.
References
Tamm I et al. (2001) Lancet Oncol. 2: 33–42
Fischer U et al. (2003) Cell Death Differ. 10: 76–100
Nunez G et al. (1998) Oncogene 17: 3237–3245
Muzio M et al. (1996) Cell 85: 817–827
Boldin MP et al. (1996) Cell 85: 803–815
LeBlanc HN and Ashkenazi A (2003) Cell Death Differ. 10: 66–75
Peter ME and Krammer PH (2003) Cell Death Differ. 10: 26–35
Eggert A et al. (2001) Cancer Res. 61: 1314–1319
Fulda S et al. (2001) Oncogene 20: 5865–5877
Teitz T et al. (2000) Nat. Med. 6: 529–535
Annicchiarico-Petruzzelli M (2001) Med. Pediatr. Oncol. 36: 115–117
Fulda S and Debatin KM (2002) Oncogene 21: 2295–2308
Yang X et al. (2003) Cancer Res. 63: 1122–1129
Banelli B et al. (2002) Nat. Med. 8: 1333–1335
Ramana CV et al. (2000) Oncogene 19: 2619–2627
Muhlethaler-Mottet A et al. (1997) EMBO J. 16: 2851–2860
Storm van's Gravesande K et al. (2002) J. Immunol. 168: 4488–4494
Tanaka N et al. (1993) Mol. Cell. Biol. 13: 4531–4538
Decker T et al. (1997) J. Interferon Cytokine Res. 17: 121–134
Liedtke C et al. (2003) J. Biol. Chem. 278: 27593–27604
Refaeli Y et al. (2002) J. Exp. Med. 196: 999–1005
Fernandes-Alnemri T et al. (1996) Proc. Natl. Acad. Sci. USA 93: 7464–7469
Himeji D et al. (2002) Blood 99: 4070–4078
Xi H and Blanck G (2003) Mol. Immunol. 39: 677–684
Blanco JC et al. (2000) J. Exp. Med. 191: 2131–2144
Falvo JV et al. (1995) Cell 83: 1101–1111
Thanos D and Maniatis T (1995) Cell 83: 1091–1100
Muhlethaler-Mottet A et al. (1998) Immunity 8: 157–166
Gongora C et al. (2000) Nucleic Acids Res. 28: 2333–2341
Boyd KE et al. (1998) Proc. Natl. Acad. Sci. USA 95: 13887–13892
Acknowledgements
B Banelli is a fellow of the Fondazione Italiana per la Ricerca sul Cancro (FIRC). M Croce is a fellow of the Fondazione Italiana per la Lotta al Neuroblastoma. This work was supported by grants from the Fondazione Italiana per la Lotta al Neuroblastoma, from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and from the Italian Health Ministry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Casciano, I., De Ambrosis, A., Croce, M. et al. Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE). Cell Death Differ 11, 131–134 (2004). https://doi.org/10.1038/sj.cdd.4401327
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401327
This article is cited by
-
Targeting the apoptosis pathway to treat tumours of the paediatric nervous system
Cell Death & Disease (2022)
-
Cell death-based treatment of neuroblastoma
Cell Death & Disease (2018)
-
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
Cell Death & Disease (2015)
-
Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen
Cancer Immunology, Immunotherapy (2008)
-
5-Aza-2′-deoxycytidine and IFN-γ cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8
Oncogene (2006)